Page last updated: 2024-09-03

astilbin and Bone Loss, Osteoclastic

astilbin has been researched along with Bone Loss, Osteoclastic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, K; Chu, F; Jin, H; Kenny, J; Pan, H; Qiu, H; Tickner, J; Wang, C; Wang, Q; Wang, T; Wang, Z; Xu, H; Xu, J; Xu, K; Ye, Z	1

Other Studies

1 other study(ies) available for astilbin and Bone Loss, Osteoclastic

Article	Year
Astilbin prevents bone loss in ovariectomized mice through the inhibition of RANKL-induced osteoclastogenesis. Journal of cellular and molecular medicine, 2019, Volume: 23, Issue:12 Topics: Animals; Bone Resorption; Cells, Cultured; Drugs, Chinese Herbal; Female; Flavonols; Gene Expression; Humans; Integrin beta3; Mice; Mice, Inbred C57BL; NFATC Transcription Factors; Osteoclasts; Osteogenesis; Ovariectomy; Phytotherapy; Proto-Oncogene Proteins c-fos; RANK Ligand; RAW 264.7 Cells; Tartrate-Resistant Acid Phosphatase	2019

Article

Year

Astilbin prevents bone loss in ovariectomized mice through the inhibition of RANKL-induced osteoclastogenesis.

Journal of cellular and molecular medicine, 2019, Volume: 23, Issue:12

Topics: Animals; Bone Resorption; Cells, Cultured; Drugs, Chinese Herbal; Female; Flavonols; Gene Expression; Humans; Integrin beta3; Mice; Mice, Inbred C57BL; NFATC Transcription Factors; Osteoclasts; Osteogenesis; Ovariectomy; Phytotherapy; Proto-Oncogene Proteins c-fos; RANK Ligand; RAW 264.7 Cells; Tartrate-Resistant Acid Phosphatase

2019